Protection of COVID-19 Vaccination Against Hospitalization During the Era of Omicron BA.4 and BA.5 Predominance: A Nationwide Case–Control Study Based on the French National Health Data System

BACKGROUND: Knowing the duration of effectiveness of coronavirus disease 2019 (COVID-19) booster doses is essential to providing decision-makers with scientific arguments about the frequency of subsequent injections. We estimated the level of protection against COVID-19-related hospitalizations (Omi...

Descripción completa

Detalles Bibliográficos
Autores principales: Semenzato, Laura, Botton, Jérémie, Le Vu, Stéphane, Jabagi, Marie-Joëlle, Cuenot, François, Drouin, Jérôme, Dray-Spira, Rosemary, Weill, Alain, Zureik, Mahmoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551849/
https://www.ncbi.nlm.nih.gov/pubmed/37808897
http://dx.doi.org/10.1093/ofid/ofad460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551849/
https://www.ncbi.nlm.nih.gov/pubmed/37808897
http://dx.doi.org/10.1093/ofid/ofad460

Ejemplares similares